Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2002
11/07/2002WO2002088106A2 Cysteine protease inhibitors
11/07/2002WO2002088097A1 Triazole-derived kinase inhibitors and uses thereof
11/07/2002WO2002088095A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/07/2002WO2002088090A2 Pyrazole derived kinase inhibitors
11/07/2002WO2002088080A2 Dual inhibitors of pde 7 and pde 4
11/07/2002WO2002088079A2 Dual inhibitors of pde 7 and pde 4
11/07/2002WO2002087747A1 Stable aqueous colloidal dispersion, method for preparing same
11/07/2002WO2002087626A1 Pharmaceutical compositions comprising dendritic cells for immunotherapy of autoimmune disease and treatment methods using the same
11/07/2002WO2002087605A2 Modified fvii in treatment of ards
11/07/2002WO2002087603A1 Immunopotentiators
11/07/2002WO2002087600A1 Use of phyllanthus constituents for treating or preventing infections caused by hepatit
11/07/2002WO2002087596A2 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases
11/07/2002WO2002087593A1 A method for treating or preventing a functional vitamin b12 deficiency in an individual and to medical compositions for use in said method
11/07/2002WO2002087583A2 Use of hiv-protease inhibitors to block cell migration and/or invasion, tissue infiltration and oedema formation
11/07/2002WO2002087579A1 Use of mangafodipir for treating oxidative stress effects
11/07/2002WO2002087573A1 Crf receptor antagonists
11/07/2002WO2002087569A1 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
11/07/2002WO2002087548A1 A pharmaceutical tablet having a high api content
11/07/2002WO2002087514A1 Fluorine coating composition and method of fluorine coating
11/07/2002WO2002087513A2 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
11/07/2002WO2002087465A2 Compositions and methods of double-targeting virus infections and cancer cells
11/07/2002WO2002087424A2 Treatment and diagnosis of macrophage mediated disease
11/07/2002WO2002066026A3 Tramadol-based medicament
11/07/2002WO2002064546A3 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/07/2002WO2002044141A3 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
11/07/2002WO2002038594A9 Novel therapeutic compositions for treating infection by lawsonia spp
11/07/2002WO2002028897A3 Human g-protein coupled receptor and uses thereof
11/07/2002WO2002009768A3 Therapeutic polyesters and polyamides
11/07/2002WO2001047866A9 Substituted 1 and 2 naphthol mannich bases
11/07/2002WO2001027079A9 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease
11/07/2002US20020165399 Interphenylene 7-oxabicyclic [2.2.1] heptane oxazoles as prostaglandin F2a antagonists
11/07/2002US20020165380 A nucleic acid probe consisting a nucleic acid molecule of at least 15 nucleotides which is complementary to the antisense sequence of a unique fragment of the sequence of a nucleic acid molecule encoding a mammalian fb41 receptor
11/07/2002US20020165275 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/07/2002US20020165268 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease
11/07/2002US20020165239 Conjugates of sodium channel blockers and methods of using the same
11/07/2002US20020165234 Selective B3 adrenergic agonists
11/07/2002US20020165223 Eating disorders; anticholesterol agents; hypotensive agents; sleep disorders
11/07/2002US20020165217 Combination treatment for anxiety and depression
11/07/2002US20020165203 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents
11/07/2002US20020165190 Expression vector coding p972 gene for cancer therapy and adenovirus producing the same
11/07/2002US20020165164 New effectors of dipeptidyl peptidase IV for topical use
11/07/2002US20020165154 Lipoprotein-regulating medicaments
11/07/2002US20020165150 Amino acid sequence from certain regions of tissue growth factor-beta super family serine-threonine kinase receptors
11/07/2002US20020164767 DNA encoding the human serine protease C-E
11/07/2002US20020164722 Generating preferential polymerase in sample; obtain nucleotide sequences, incubate in reaction mixture, translate nucleotide sequences, recover polypeptide
11/07/2002US20020164719 Targeting pharmaceutical agents to injured tissues
11/07/2002US20020164707 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer, arthrits, pain, diabetes, migraine and inflammation, hypercalcemia, obesity, hypertension, and bone defects
11/07/2002US20020164682 Mammalian cerberus-like protein and compositions
11/07/2002US20020164377 Mixture of retinoic acid and paclitaxel; polymeric carrier
11/07/2002US20020164355 Test to detect antibodies; calibration
11/07/2002US20020164349 Induction apoptosis; west nile virus therapy
11/07/2002US20020164312 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/07/2002CA2594883A1 Pharmaceutically active uridine esters
11/07/2002CA2447748A1 Use of hiv-protease inhibitors to block cell migration and/or invasion, tissue infiltration and oedema formation
11/07/2002CA2446514A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/07/2002CA2446497A1 Crf receptor antagonists
11/07/2002CA2445861A1 Pharmaceutically active uridine esters
11/07/2002CA2445839A1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
11/07/2002CA2445826A1 Treatment and diagnosis of macrophage mediated disease
11/07/2002CA2445819A1 Recombinant expression of hhbv reverse transcriptase (rt)
11/07/2002CA2445811A1 Modified fvii in treatment of ards
11/07/2002CA2445702A1 Control of compactability through crystallization
11/07/2002CA2445568A1 Triazole-derived kinase inhibitors and uses thereof
11/07/2002CA2445565A1 Compositions and methods of double-targeting virus infections and cancer cells
11/07/2002CA2445376A1 Substance rkb-3564 having angiogenesis inhibitory action
11/07/2002CA2445373A1 Use of phyllanthus constituents for treating or preventing infections caused by hepatitis b viruses
11/07/2002CA2445357A1 Pyrazole derived kinase inhibitors
11/07/2002CA2445348A1 Novel benzylpiperidine compound
11/07/2002CA2445338A1 G-protein coupled receptors
11/07/2002CA2445294A1 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
11/07/2002CA2445290A1 A pharmaceutical tablet having a high api content
11/07/2002CA2444436A1 Dual inhibitors of pde 7 and pde 4
11/07/2002CA2443838A1 Use of mangafodipir for treating oxidative stress effects
11/07/2002CA2443835A1 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
11/07/2002CA2443381A1 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases
11/07/2002CA2440775A1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use
11/07/2002CA2429001A1 Cysteine protease inhibitors
11/06/2002EP1255112A2 Treatment of T-cell mediated diseases
11/06/2002EP1254907A1 Pyrrolopyridazine compound
11/06/2002EP1254905A1 4-(2-Pyridyl)piperazines having 5HT7 receptor agonist activity
11/06/2002EP1254902A1 Agents correcting gene expression regulatory error
11/06/2002EP1254898A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
11/06/2002EP1254890A1 Derivatives of 3,3-diphenylpropylamines
11/06/2002EP1254668A2 Combination of a serotonin reuptake inhibitor and a GABA-A alpha 2/3 agonist for use in anxiety and depression
11/06/2002EP1254667A1 Drug comprising combination
11/06/2002EP1254268A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
11/06/2002EP1254259A1 Antisense modulation of pepck-cytosolic expression
11/06/2002EP1254255A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies
11/06/2002EP1254242A1 17 human secreted proteins
11/06/2002EP1254236A2 Drug metabolizing enzymes
11/06/2002EP1254235A2 Drug metabolizing enzymes
11/06/2002EP1254220A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same
11/06/2002EP1254212A2 Methods of preparing and using a viral vector library
11/06/2002EP1254176A2 Trade molecules and uses related thereto
11/06/2002EP1254143A2 Lipid-based drug delivery systems
11/06/2002EP1254139A1 4-heteroaryl-1,4-diazabicyclo 3.2.2]nonane, preparation and therapeutic use thereof
11/06/2002EP1254134A2 1,3-dihydro-2h-indol-2-one derivatives,and their use as ligands for v1b or v1b and v1a arginine-vasopressin-receptors
11/06/2002EP1254124A1 Dipeptide nitrile cathpsin k inhibitors
11/06/2002EP1254123A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
11/06/2002EP1254119A1 Pyrimidine derivatives as selective inhibitors of cox-2
1 ... 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 ... 1258